Drug Trial Radar · NCT00001061
Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS
Last checked: Nov 19, 2026Latest source record: Nov 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
167
Actual
Start
Not stated
Primary completion
Not stated
Study completion Mar 1998
Sponsor
- Sponsor type
- NIH
- Collaborators
- Facet Biotech
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the effect of MSL 109, human monoclonal anti-cytomegalovirus (CMV) antibody, on time to progression of CMV retinitis. To determine the safety and pharmacokinetic profile of MS 109. To evaluate the relationship between pharmacokinetic measurements of MSL 109 and efficacy and virologic markers. Therapeutic agents currently available for CMV retinitis are limited by their inherent toxicities and short half-lives which require frequent intravenous dosing. Alternatively, MSL 109 has demonstrated safety and effectiveness in neutralizing CMV isolates at concentrations easily maintained in AIDS patients.
Conditions
- Cytomegalovirus Retinitis
- HIV Infections
Interventions
SevirumabDrug
Foscarnet sodiumDrug
GanciclovirDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Alabama Therapeutics CRS
Birmingham, Alabama
USC CRS
Los Angeles, California
Santa Clara Valley Med. Ctr.
San Jose, California
Stanford CRS
Stanford, California
University of Colorado Hospital CRS
Aurora, Colorado
Univ. of Miami AIDS CRS
Miami, Florida
Queens Med. Ctr.
Honolulu, Hawaii
Univ. of Hawaii at Manoa, Leahi Hosp.
Honolulu, Hawaii
Cook County Hosp. CORE Ctr.
Chicago, Illinois
Rush Univ. Med. Ctr. ACTG CRS
Chicago, Illinois
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
Indianapolis, Indiana
Massachusetts General Hospital ACTG CRS
Boston, Massachusetts
Beth Israel Deaconess - East Campus A0102 CRS
Boston, Massachusetts
Beth Israel Deaconess Med. Ctr., ACTG CRS
Boston, Massachusetts
Washington U CRS
St Louis, Missouri
SUNY - Buffalo, Erie County Medical Ctr.
Buffalo, New York
Univ. of Rochester ACTG CRS
Rochester, New York
Univ. of Cincinnati CRS
Cincinnati, Ohio
Case CRS
Cleveland, Ohio
Hosp. of the Univ. of Pennsylvania CRS
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.